Clinical Trials Directory

Trials / Terminated

TerminatedNCT01742338

Dose of Corticosteroids in COPD

Determining Optimal Dose of Corticosteroids in COPD Exacerbations: A Pilot Study

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

COPD (chronic obstructive pulmonary disease) is a long-lasting lung disease usually caused by long-term smoking. COPD can get worse, making people sick enough to need hospitalization. Corticosteroids are very effective and are almost always used, but nobody knows the right dose. High doses may work better but could cause more side effects than low doses. Typical treatment lengths last at least one week. This study will be comparing two common regimens: either 40mg of corticosteroids daily (low dose), or 80mg of corticosteroids daily (high dose). It is unknown which regimen works better..

Detailed description

The goal of the study is to determine whether a high-dose corticosteroid regimen in patients admitted to the hospital with COPD exacerbations is associated with better clinical outcomes and at acceptable risk of adverse effects compared to a low-dose corticosteroid regimen. Our hypothesis is that high-dose corticosteroids is associated with a decreased rate of treatment failure, shorter length of hospital stay, and improved quality of life with similar risk of adverse effects. The study population includes patients ≥ 40 years-old with a ≥ 10 pack-years smoking history and a diagnosis of COPD, emphysema, or chronic bronchitis who present to the emergency room with increased dyspnea, increased sputum, or increased cough that requires admission to the hospital. We will perform a prospective, randomized, double-blinded study to determine if a high-dose corticosteroid regimen, which is already in use in clinical practice, decreases treatment failure compared to a low-dose corticosteroid regimen that is based on national consensus guidelines.

Conditions

Interventions

TypeNameDescription
DRUGLow Dose Corticosteroids
DRUGHigh Dose Corticosteroids

Timeline

Start date
2012-05-03
Primary completion
2020-03-15
Completion
2020-03-15
First posted
2012-12-05
Last updated
2024-04-10
Results posted
2024-04-10

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01742338. Inclusion in this directory is not an endorsement.